Jane Dewi Tahir, Chief Executive Director of Akasia 365mc Indonesia, was honored with the Grand Prize for Best Brand (AI Liposuction category) at the 19th Korea Healthcare Industry Awards, held on July 3 at the Riverside Hotel in Seoul.

Akasia 365mc Indonesia Chief Executive Director Jane Dewi Tahir poses for a commemorative photo after receiving the Grand Prize for Best Brand (AI Liposuction category) at the 19th Korea Healthcare Industry Awards, held at The Riverside Hotel in Seoul last Thursday. (Credit: 365mc)
Akasia 365mc Indonesia Chief Executive Director Jane Dewi Tahir poses for a commemorative photo after receiving the Grand Prize for Best Brand (AI Liposuction category) at the 19th Korea Healthcare Industry Awards, held at The Riverside Hotel in Seoul last Thursday. (Credit: 365mc)

Tahir received the award on behalf of obesity-focused medical group 365mc, in recognition of its leadership in AI-powered liposuction technology and its rapid global expansion, particularly in Southeast Asia.

Organized by the Health Industry CEO Summit, a gathering of healthcare leaders, the awards reflect the growing interest in qualitative healthcare metrics such as precision medicine, AI integration, and international patient services, beyond traditional measures like patient volume or surgical case counts.

365mc was recognized for its pioneering development of AI-based liposuction systems and for opening overseas branches in Indonesia and Thailand, showcasing its global competitiveness.

Since entering the Indonesian market in July 2023, the group has opened three local clinics and surpassed 30,000 RAMS bottle extractions -- a proprietary procedure volume indicator -- within just 16 months.

Tahir, who accepted the award on behalf of 365mc, has played a key role in localizing the Korean clinic’s medical model through collaboration with Indonesian healthcare corporations.

“The reason 365mc’s advanced Korean medical technology could be replicated abroad lies in our AI-based, standardized treatment system,” she said. “The scalability of this system will continue to accelerate our global growth.”

365mc began its investment in AI-driven medical systems in 2017. In 2020, it registered a patent for an AI-powered cannula surgery diagnostic device that analyzes surgical motion data to improve prediction accuracy and inform personalized postoperative care.

That same year, the company co-developed the M.A.I.L. System (Motion capture and Artificial Intelligence assisted Liposuction) with Microsoft and registered the joint technology as a global patent.

In April, 365mc signed an agreement with Naver Cloud, Cloocus, and the Korea Advanced Institute of Science and Technology (KAIST) to co-develop an exportable AI-based clinical system. The project integrates AI cloud computing with electronic medical records to provide real-time analysis of patient data and deliver personalized, efficient care.

Meanwhile, the group currently operates four overseas branches -- three in Indonesia (two in Jakarta and one in Surabaya) and one in Thailand. It is preparing to open new clinics in Ho Chi Minh City, Vietnam, and Los Angeles, U.S. in the second half of this year.

Related articles

Copyright © KBR Unauthorized reproduction, redistribution prohibited